Union Minister of Commerce and Industry Shri Piyush Goyal Calls on MedTech Startups to Go Global, Leverage Trade Pacts Covering 70% of World GDP

1. At a Glance

• Union Minister of Commerce & Industry Piyush Goyal urged Indian MedTech startups to scale globally by leveraging India's 9 FTAs covering 38 countries and ~70% of world GDP at mostly zero duty [S1][S2].
• Announcement bundles trade-policy (FTAs), industrial-R&D (NIPER expansion, new NID), and startup-ecosystem (80% IP-fee rebate) levers — a one-stop convergence relevant to GS-II (Govt schemes) and GS-III (Economy, S&T, IPR).

2. Why in the News

• On 12 Feb 2026, Goyal addressed the Pfizer INDovation Startup Showcase Programme, New Delhi, exhorting MedTech startups to "Go Global" [S1].
• Coincides with cascade of new FTAs: India–UK CETA (Jul 2025), India–Oman CEPA (Dec 2025), India–New Zealand FTA (22 Dec 2025), India–EU FTA (27 Jan 2026), and India–US interim framework (7 Feb 2026) [S2].

3. Background & Evolution

• NIPER: First established at Mohali (1998) under the NIPER Act, 1998; declared Institute of National Importance; admin ministry — Dept. of Pharmaceuticals, Ministry of Chemicals & Fertilizers [S3].
• Startup India: Launched 16 Jan 2016; 80% rebate on patent filing fees and 50% on trademark fees are flagship IPR sops [S1].
• FTA trajectory: India–Mauritius CECPA (2021) → India–UAE CEPA (May 2022) → India–Australia ECTA (Dec 2022) → India–EFTA TEPA (signed 10 Mar 2024, in-force 1 Oct 2025) → UK/Oman/NZ/EU/US in 2025–26 [S2].

4. Core Static Facts

• Programme platform: Pfizer INDovation Startup Showcase, New Delhi, 12 Feb 2026 [S1].
• Speaker: Shri Piyush Goyal, Union Minister of Commerce & Industry [S1].
• FTA count: 9 FTAs in ~3 years; 38 countries; ~70% of global GDP; "mostly zero duty" market access [S1][S2].
• NIPER expansion: 3 new NIPERs + upgradation of 7 existing NIPERs; existing NIPERs at Mohali, Ahmedabad/Gandhinagar, Hyderabad, Kolkata, Guwahati, Hajipur, Raebareli [S1][S3].
• New NID (National Institute of Design) to be set up in East India [S1].
• IPR sop: 80% rebate on IP filing fees for recognized startups; 24x7 Startup India team support [S1].
• Parent Ministry: Ministry of Commerce & Industry — DPIIT runs Startup India [S1].

5. Multi-Dimensional Analysis

Economic - FTAs unlock duty-free access for India's $50+ bn pharma export base and nascent MedTech segment (currently ~75% import-dependent) [S1][S2]. - Aligns with PLI for Medical Devices (DoP) and Promotion of Medical Device Parks scheme.

Scientific / Technological - NIPER upgradation feeds R&D pipeline for biosimilars, medical devices, phytopharmaceuticals (CoEs at Ahmedabad, Hyderabad, Guwahati, Mohali) [S3]. - Biopharma SHAKTI envisages institutional network of 3 new + 7 upgraded NIPERs [S3].

Geopolitical / Strategic - FTA web with UAE, Australia, EFTA, UK, Oman, NZ, EU, US reorients India away from RCEP (which India exited in Nov 2019) toward bilateral/plurilateral deals with developed markets [S2].

Administrative / Governance - Convergence of three ministries — Commerce (FTAs, Startup India), Chemicals & Fertilizers (NIPER), Textiles (NID) — under one ministerial portfolio held by Goyal.

Legal / IPR - IP-fee rebate operates under Startup India Action Plan, 2016 and SIPP (Scheme for Facilitating Startups Intellectual Property Protection) [S1].

6. Recent Developments (12–18 months)

• 10 Mar 2024: India–EFTA TEPA signed; 1 Oct 2025: entered into force [S2].
• Jul 2025: India–UK CETA signed [S2].
• Dec 2025: India–Oman CEPA; India–New Zealand FTA (22 Dec 2025) [S2].
• 27 Jan 2026: India–EU FTA concluded [S2].
• 7 Feb 2026: India–US interim trade framework delivered [S2].
• 12 Feb 2026: Goyal's MedTech address at Pfizer INDovation [S1].

7. Prelims Hooks

• India has signed 9 FTAs covering 38 countries (~70% of global GDP) as of Feb 2026 [S1][S2].
• EFTA TEPA in-force date: 1 October 2025; EFTA = Switzerland, Norway, Iceland, Liechtenstein [S2].
• NIPER Act, 1998 — Institutes of National Importance under Dept. of Pharmaceuticals, NOT Ministry of Education [S3].
• Existing NIPERs = 7 (Mohali, Ahmedabad, Hyderabad, Kolkata, Guwahati, Hajipur, Raebareli) [S3].
• Startup India launched 16 Jan 2026 — admin by DPIIT under Commerce Ministry [S1].
• 80% rebate on patent fees for recognised startups (SIPP scheme) [S1].
• India–UAE CEPA = India's first CEPA with an Arab nation, signed Feb 2022, in-force May 2022 [S2].
• India–Australia ECTA in force from 29 Dec 2022 [S2].
• India–EU FTA announced 27 January 2026 [S2].
• Pfizer INDovation = pharma industry–startup showcase; venue New Delhi, 12 Feb 2026 [S1].
• New NID announced for East India — NIDs are under Ministry of Commerce & Industry (DPIIT), not Culture/Education.
• India exited RCEP in November 2019 — context for pivot to bilateral FTAs.

8. Mains Relevance

• GS-II: Government policies & interventions — Startup India, IP regime.
• GS-III: Indian Economy (FTAs, exports); Science & Tech (pharma/MedTech R&D); IPR.
• Possible stems: 1. "India's recent FTAs mark a strategic pivot toward bilateral engagement with developed economies. Discuss in the context of the MedTech and pharma sectors." (GS-III) 2. "Evaluate the role of NIPERs and the Startup India IPR framework in building India as a global MedTech hub." (GS-III) 3. "Examine how trade agreements covering 70% of world GDP can be leveraged for Atmanirbhar Bharat in healthcare." (GS-III)

9. Related Topics to Study Next

• PLI Scheme for Medical Devices & Bulk Drugs — supply-side complement.
• India–EU FTA / India–UK CETA — flagship 2025–26 deals.
• Patents (Amendment) Rules 2024 — IPR ecosystem.
• Jan Aushadhi & PMBJP — domestic affordability angle.
• DCGI & CDSCO — MedTech regulatory architecture.
• National Medical Devices Policy 2023 — sectoral roadmap.
• RCEP exit (2019) — comparative trade strategy.
• Startup India Seed Fund Scheme (SISFS) — financing layer.

10. Common Errors / Trap Areas

• NIPER ≠ NIPFP. NIPER (Pharma, Dept. of Pharmaceuticals); NIPFP (Public Finance, Finance Ministry).
• NID is under DPIIT (Commerce Ministry), not Ministry of Education or Culture.
• EFTA ≠ EU. EFTA = Switzerland, Norway, Iceland, Liechtenstein; India–EU FTA is separate (Jan 2026).
• "9 FTAs" is the count touted in Feb 2026 — older sources may say 13 (counts include older CECAs with Singapore, Japan, Korea, ASEAN).
• Startup IP rebate is 80% on patents and 50% on trademarks — don't conflate.
• India–UAE deal is a CEPA, India–Australia is ECTA (interim), India–UK is CETA — terminology distinct.

11. Sources

• [S1] Piyush Goyal Calls on MedTech Startups to Go Global … — https://www.pib.gov.in/PressReleasePage.aspx?PRID=2226987 — (tier 1; user-supplied excerpt; live fetch returned 403)
• [S2] FTAs Opening New Opportunities for Pharma, Healthcare and MedTech Sectors — https://www.pib.gov.in/PressReleasePage.aspx?PRID=2237181 — (tier 1)
• [S3] Transforming India into a Global Biopharma Hub / NIPER CoEs — https://www.pib.gov.in/PressNoteDetails.aspx?NoteId=157147 and https://www.pib.gov.in/PressReleaseIframePage.aspx?PRID=2069310 — (tier 1)